Bryan Pearce is a partner in the technology and life sciences practice of the firm, based in Boston MA, where he leads the firm's New England Venture Capital Advisory Group ("VCAG"). VCAG focuses on development and delivery of value added services to the venture capital industry, including core audit and tax services as well as deal flow, knowledge and thought leadership, and access to our alumni and extended enterprise networks and perspective on current venture capital fundraising trends. In addition, Bryan spends a substantial portion of his time with Emerging Growth companies providing counsel in the areas of fundraising, business models, preparing for a liquidity event, etc. He also is a member of the Global Steering Committee for this important component of the Global E&Y strategy.
Bryan began his career with the firm in 1981 after graduating from the Ivey School of Business at the University of Western Ontario (Canada) and obtained his Canadian Chartered Accountant designation in 1983. Between 1995 and 2000 Bryan was seconded to the Caribbean practice, based in Barbados, where he was responsible for developing and running the Caribbean firm's Corporate Finance and Entrepreneurial Services' practice.
Now when you look at the healthcare as a subset of that, we have about 480 venture backed biotech companies in the country. About 383 medical device companies. And between them they have raised about $22 billion of venture capital over history. Basically if you look at where those companies are, and...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
